UBS Raises PT on UnitedHealth Group Incorporated (UNH) to $378, Maintains ‘Buy’ Rating

Group 1 - UnitedHealth Group Incorporated (NYSE:UNH) is recognized as one of the Top 15 Stocks to Buy across 11 different sectors for the next 3 months [1] - UBS has raised its price target for UnitedHealth Group from $330 to $378 while maintaining a 'Buy' rating, following the reaffirmation of 2025 guidance and steady Stars ratings through 2027 [2] - The company operates globally through its UnitedHealthcare insurance arm and Optum's analytics, pharmacy, and care delivery businesses, making it one of the Best Diversified Stocks [3] Group 2 - Despite the potential of UnitedHealth as an investment, certain AI stocks are considered to offer greater upside potential with less downside risk [4]